Login / Signup
Xuehan Zou
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Acinetobacter Baumannii
Silver Nanoparticles
Drug Resistant
Current Status
Top Venues
Infection and drug resistance
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xuehan Zou
,
Shaojun Jin
,
Lingxia Chen
,
Jie Li
,
Xiaofan Zhang
,
Hua Zhou
,
Xi Li
,
Haijun Huang
Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study.
Infection and drug resistance
16 (2023)
Xuehan Zou
,
Shaojun Jin
,
Lingxia Chen
,
Jie Li
,
Xiaofan Zhang
,
Hua Zhou
,
Xi Li
,
Haijun Huang
Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study.
Infection and drug resistance
16 (2023)
Xinli Mu
,
Jianghong Liang
,
Linyan Qian
,
Bing Zhou
,
Xuehan Zou
,
Ying Fu
,
Yongze Zhu
,
Xi Li
,
Jiana Shi
Genome Analysis of ST1 Bartonella henselae , a Zoonotic Pathogen Causing Endocarditis in an Elderly Patient in China.
Infection and drug resistance
16 (2023)
Xuehan Zou
,
Shaojun Jin
,
Lingxia Chen
,
Jie Li
,
Xiaofan Zhang
,
Hua Zhou
,
Xi Li
,
Haijun Huang
Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study.
Infection and drug resistance
16 (2023)
Xuehan Zou
,
Shaojun Jin
,
Lingxia Chen
,
Jie Li
,
Xiaofan Zhang
,
Hua Zhou
,
Xi Li
,
Haijun Huang
Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study.
Infection and drug resistance
16 (2023)